Propofol (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the Propofol drug offered from Actavis Pharma, Inc.. This General Anesthesia [PE],General Anesthetic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: Propofol
SUBSTANCE NAME: PROPOFOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: General Anesthesia [PE],General Anesthetic [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, EMULSION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-12-28
END MARKETING DATE: 0000-00-00


Propofol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPropofol from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2015-12-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0591-2136_b2ee1715-2baa-4b7e-98ae-da3fe34184c0
PRODUCT NDC: 0591-2136
APPLICATION NUMBER: ANDA205307

Other PROPOFOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Propofol
APP Pharmaceuticals, LLCPropofol
Fresenius Kabi USA, LLCDiprivan
General Injectables & Vaccines, IncDiprivan
General Injectables and Vaccines, IncPropofol
Hospira, Inc.PROPOFOL
Sagent Pharmaceuticalspropofol